Figures in White House, Congress - including National Security Advisor Marco Rubio - pushing for "disclosure" of classified records on UFOs.

The COVID-19 pandemic has had a massive impact on every aspect of our daily lives, in ways which we may not even notice. Its effect on our architecture and built environment is no exception – public ...

“Know thyself” is an ancient Greek phrase that emphasises the importance of understanding one’s own character because this allows you to be aware of one’s limitations. Lovisa (ASX: LOV) is a ...

With the vision to celebrate all that is art and inspire art lovers, collectors, buyers and the art curious annually under one roof, ‘Sydney Contemporary’ 2023 delivers its most impressive program to ...

I recently appeared on the Australian Investors Podcast to talk about the general macroeconomic investing environment with Owen Raszkiewicz. We talk about the impossibility of picking the bottom of ...

When undercooked, the mushroom known in PNG, the Philippines and Yunnan, China is associated with the appearance of "little people".

I am writing a quick note on why I bought Codan (ASX: CDA) shares, because even though I have followed the company for many years, I haven’t covered it on these pages. As a quick primer, Codan is a ...

This morning, radiology software company Pro Medicus (ASX: PME) reported its results for the first half of 2024, and in response, the share price has fallen around 11% from $108 to $95.70 at the time ...

Cloud accounting software program Xero Ltd (ASX: XRO) yesterday reported their full year 2024 results. In response, the Xero share price gained around 8% to trade above $134 AUD. For FY 2024, Xero ...

One common question for investors is; “What is The Rule Of 40?” While the Rule of 40 is always measuring a proxy of owner earnings and growth, the exact measures used to calculate the rule of 40 can ...

Mining software and consulting company RPM Global (ASX: RUL) recently reported its results for FY 2023, boasting a net profit after tax of $3.7 million on revenue of $97.4 million. Revenue was up ...

Ketamine will be available under Medicare and the Pharmaceutical Benefits Scheme (PBS) for treatment-resistant depression. It will be administered as a nasal spray under the brand name Spravato. It ...